Recently, Alnomasy et al. (2022) showed the promising anti-cancer effects of royal jelly against HepG2 with a CC50 value of 1.13 mg/mL; in addition, RJ upregulated expression of the miR-34a, Caspase-3, and Bax genes and proteins [17]. This evidence concerns the gene BAX and cancer.